EUVIMEDEUVIMED entdecken
Crossref

The Effects of Warfarin and Novel Oral Anticoagulants on Depression and Anxiety in Patients with Non-Valvular Atrial Fibrillation

Neslihan Cansel, Muhammed Yasin Adıgüzel, Şahide Nur Ipek Melez, Adil Bayramoğlu

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · 2025

DOI: 10.5543/tkda.2025.79458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2025. Verfasst von Neslihan Cansel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Inonu University Faculty of Medicine, Malatya, Türkiye. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Warfarin, Depression.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia and has a detrimental impact on psychological well-being. This study aims to determine the prevalence of anxiety and depression in patients with non-valvular AF and to investigate the relationship between these psychological conditions and the treatment regimens administered. METHOD: This cross-sectional study included 255 individuals diagnosed with non-valvular AF who were treated between 2021 and 2022. Psychiatric evaluation was conducted using the Beck Depression Inventory and Beck Anxiety Inventory. Multivariate regression analysis was performed to identify predictors of depression and anxiety. RESULTS: Of the patients included, 62 were on warfarin, 124 were on novel oral anticoagulants (NOACs), and 69 were not receiving any oral anticoagulant (OAC) therapy. Overall, 68.6% had depression and 64.7% had anxiety at a moderate or higher severity level. Although there was no notable variation in anxiety and depression scores between patients on NOACs and those not undergoing OAC treatment, the warfarin group had significantly higher scores than the other two groups. Age, anxiety, C-reactive protein (CRP) levels, and CHA2DS2-VASc scores (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes mellitus, prior Stroke/transient ischemic attack-Vascular disease, Age 65-74 years, Sex category) all positively correlated with the severity of depression. Anxiety, in turn, was positively associated with age, depression, and CHA2DS2-VASc scores, and negatively associated with ejection fraction. Regression analysis revealed a strong correlation between warfarin treatment and anxiety severity. CONCLUSION: The findings of this study suggest that warfarin treatment is associated with significant psychological effects in patients with AF. Considering that comorbid psychiatric disorders are linked to unfavorable prognosis and higher mortality, the development of appropriate intervention strategies that address psychological distress as part of the treatment process may provide substantial clinical benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsWarfarinDepressionAnxietyHumansMaleFemaleCross-Sectional StudiesAgedMiddle AgedAdministration, OralAged, 80 and overPrevalence

Substanzen

AnticoagulantsWarfarin

Autor:innen und Institutionen

  • Department of Psychiatry, Inonu University Faculty of Medicine, Malatya, Türkiye.
  • Department of Cardiology, Malatya Training and Research Hospital, Malatya, Türkiye.
  • Department of Internal Medicine, Gaziantep University Medical Faculty, Gaziantep, Türkiye.
  • Department of Cardiology, Inonu University Faculty of Medicine, Malatya, Türkiye.

Zitieren

APA

Cansel, N., Adıgüzel, M. Y., Melez, Ş. N. I., & Bayramoğlu, A. (2025). The Effects of Warfarin and Novel Oral Anticoagulants on Depression and Anxiety in Patients with Non-Valvular Atrial Fibrillation. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. https://doi.org/10.5543/tkda.2025.79458

Vancouver

Cansel N, Adıgüzel MY, Melez ŞNI, Bayramoğlu A. The Effects of Warfarin and Novel Oral Anticoagulants on Depression and Anxiety in Patients with Non-Valvular Atrial Fibrillation. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 2025. doi:10.5543/tkda.2025.79458

BibTeX
@article{Cansel2025,
  author = {Cansel, Neslihan and Adıgüzel, Muhammed Yasin and Melez, Şahide Nur Ipek and Bayramoğlu, Adil},
  title = {The Effects of Warfarin and Novel Oral Anticoagulants on Depression and Anxiety in Patients with Non-Valvular Atrial Fibrillation},
  journal = {Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology},
  year = {2025},
  doi = {10.5543/tkda.2025.79458}
}
Kostenlos starten →